Citation:U.S. National Library of Medicine 2016

From Cancer Guidelines Wiki


U.S. National Library of Medicine. [homepage on the internet] USA: NIH; 2016 Dec 1 [cited 2019 May 24; updated 2019 May 21]. Available from:

This is a publication of NCT02978625

Critical appraisals

Compare quality appraisals for each clinical question

Cited by

  1. 12.3 Metastatic disease and systemic therapies: health system implications and discussion

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers